WHO

In the pharmaceutical industry the course is designed to give you the skills that have taken many experienced auditors decades to develop. It follows the auditing guidance of ISO-19011 and is a virtual audit of a manufacturing facility that makes a range of dosage forms. This allows you to plan and prepare audits of the supplier and your own supplier audit system. Throughout the course, there is personal practice with exercises and teamwork’s in planning, preparation and performance that address WHO. The extensive of course notes and excellent lectures given by knowledgeable and professional tutors in pharmaceutical industry, The WHO was very easy to approach with any problems in during the course. The purpose of regulatory authorities to assess application for authorization to market products for human use and either grant authorizations to market each product or reject such applications and inspect the manufacturers and wholesalers of medicines for human use and either grant manufacturing and wholesale licenses or refuse such licenses. The international regulatory authorities under consideration are in this article WHO, USFDA, MHRA, and Australian TGA. The standard institutions give the economical background for development and transferring technologies, ISI, ISO, BISS and ASTM. 

Plants have been used as medicines for thousands of years. They have always been used as a rich source of biologically active drugs. According to WHO (World Health Organization) report, about 80% of the population, mostly in developing countries still depends on traditional medicinal system for their primary health care. The present investigation is focused on the phytochemical investigation of abutilon indicum species for anticancer activity. The Abutilon L. genus of the Malvaceae family comprises about 150 annual or perennial herbs, shrubs or even small trees widely distributed in the tropical and subtropical countries. The aqueous extract of the A. indicum L. showed significant cytotoxic activity against both the selected cancer cell lines viz. human breast cancer cell line MCF 7 and human lung cancer cell line A 549.